Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,122,000 | 935,000 | 717,824 | 1,184,000 | 935,000 |
| Marketable Securities | 152,000 | 1,548,000 | 1,603,576 | 149,000 | 154,000 |
| Inventories | 2,191,000 | 2,144,000 | 2,094,284 | 2,261,000 | 2,324,000 |
| Income taxes - deferred | N/A | N/A | 872,676 | N/A | N/A |
| Other current assets | 7,329,000 | 6,248,000 | 4,533,371 | 7,202,000 | 7,423,000 |
| TOTAL | $10,794,000 | $10,875,000 | $10,019,252 | $10,796,000 | $10,836,000 |
| Non-Current Assets | |||||
| PPE Net | 6,762,000 | 6,866,000 | 6,860,277 | 6,744,000 | 6,860,000 |
| Intangibles | 1,798,000 | 1,834,000 | 1,851,339 | 1,750,000 | 1,781,000 |
| Other Non-Current Assets | 3,141,000 | 3,195,000 | 3,234,681 | 3,041,000 | 2,571,000 |
| TOTAL | $11,701,000 | $11,895,000 | $11,946,296 | $11,535,000 | $11,212,000 |
| Total Assets | $22,495,000 | $22,770,000 | $21,965,549 | $22,331,000 | $22,048,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,525,000 | 2,051,000 | 2,128,695 | 1,892,000 | 1,983,000 |
| Accounts payable and accrued liabilities | 7,342,000 | 7,463,000 | 761,871 | 7,180,000 | 6,830,000 |
| Other current liabilities | N/A | N/A | 3,411,556 | N/A | N/A |
| TOTAL | $9,867,000 | $9,514,000 | $9,450,774 | $9,072,000 | $8,813,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,405,000 | 2,469,000 | 2,112,866 | 1,522,000 | 1,568,000 |
| Other Non-Current Liabilities | 1,877,000 | 1,781,000 | 1,141,085 | 1,703,000 | 1,698,000 |
| TOTAL | $5,080,000 | $5,084,000 | $4,117,680 | $4,038,000 | $4,074,000 |
| Total Liabilities | $14,947,000 | $14,598,000 | $13,568,454 | $13,110,000 | $12,887,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,516,000 | 1,536,000 | 1,546,453 | 1,560,000 | 1,559,000 |
| Retained earnings | 3,135,000 | 3,741,000 | 3,946,999 | 4,856,000 | 4,828,000 |
| Other shareholders' equity | 1,894,000 | 1,874,000 | 1,869,233 | 1,849,000 | 1,849,000 |
| TOTAL | $6,750,000 | $7,338,000 | $7,533,366 | $8,408,000 | $8,353,000 |
| Total Liabilities And Equity | $21,697,000 | $21,936,000 | $21,101,820 | $21,518,000 | $21,240,000 |